StonvexLoading…
StonvexStonvexStonvexCore line items from RLI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.88B | $1.77B | $1.51B | $1.70B |
Operating Income | $505.98M | $427.55M | $377.26M | $720.68M |
Net Income | $403.34M | $345.78M | $304.61M | $583.41M |
EPS (Diluted) | $4.37 | $3.74 | $3.31 | $6.37 |
Total Assets | $6.16B | $5.63B | $5.18B | $4.77B |
Total Liabilities | $4.38B | $4.11B | $3.77B | $3.59B |
Cash & Equivalents | $51.56M | $39.79M | $36.42M | $22.82M |
Free Cash Flow OCF − CapEx | $608.70M | $555.51M | $458.34M | $244.56M |
Shares Outstanding | 91.88M | 91.74M | 91.28M | 45.47M |